- poor
blood brain barrier penetration, few
central effects) L-372,662
Nolasiban Retosiban (GSK-221,149) SSR-126,768 WAY-162,720 –
centrally active following...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
-
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin...
